Skip to content
Thursday 13 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,772.67
-0.56%
DAX
26,299.74
-0.12%
CAC 40
8,650.56
-0.28%
STOXX 50
6,545.47
+0.18%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Thursday 08 December 2016 6:47 pm

Sweden launches campaign to host drugs agency post-Brexit

By: Billy Bambrough

Add as a preferred source on Google

The Swedish government has launched a campaign to become the new host of the London-based European drugs agency after the UK voted to leave the European Union.

The European Medicines Agency (EMA) employees nearly 900 people and having EMA headquartered in or near Stockholm would boost Sweden’s drugs and life science sector, its government said.

“With one of Europe’s top national medicines agencies, an excellent climate for research and life science as well as good conditions for an efficient relocation, Sweden is a good future home for the EMA,” health care minister Gabriel Wikstrom said in a statement.

Sweden has thrown its hat in the ring along with Spain, France, Poland, Italy, Denmark, and Ireland.

Sweden already hosts the European Centre for Disease Prevention and Control (ECDC).

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Trending Articles

  • Royal Hospital Chelsea to host top Arabian horse competition

  • Voi rides on in London borough despite council order

  • Milliman names Jim Fulton next CEO

  • ReNew Reports 25.6% Reduction in Scope 1 & 2 Emissions and 24.7 Billion Units of Clean Power Generated in FY 2025-26

  • Revolut chatbot goes rogue by charging users to cancel subscription

More from Morning Wire

  • Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

    Business Wire
  • Sweeping job cuts at GSK to fund £400m Cambridge campus

    Pharma
    Modern GSK Cambridge campus buildings with sky bridge, green spaces, and people walking and cycling.
  • Has Range Rover just abandoned the SUV?

    Motoring
    Range Rover GT side profile in camouflage wrap, parked in an anechoic chamber for acoustic testing.
  • ROYC and PwC Sweden Collaborate to Digitalize Private Equity Structuring & Fund Operations

    Business Wire
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Planet Opens London Office, Expanding European Footprint

    Business Wire
  • Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Blurry Close-Up Vision (Presbyopia) in Adults

    Business Wire
  • Tale of two cities: London leaps ahead in global finance but domestic growth stalls

    Economics
    Getty Images number 2154617464 depicts a relevant scene for the articles unidentified content, suitable for business context.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook